The Central Role of pH in the Clinical Pharmacology of Nicotine: Implications for Abuse Liability, Cigarette Harm Reduction and FDA Regulation
- PMID: 35220591
- PMCID: PMC9035094
- DOI: 10.1002/cpt.2555
The Central Role of pH in the Clinical Pharmacology of Nicotine: Implications for Abuse Liability, Cigarette Harm Reduction and FDA Regulation
Erratum in
-
Erratum.Clin Pharmacol Ther. 2022 Aug;112(2):411. doi: 10.1002/cpt.2693. Epub 2022 Jul 11. Clin Pharmacol Ther. 2022. PMID: 35816675 No abstract available.
Conflict of interest statement
Figures
Comment on
-
The pH of Smokeless Tobacco Determines Nicotine Buccal Absorption: Results of a Randomized Crossover Trial.Clin Pharmacol Ther. 2022 May;111(5):1066-1074. doi: 10.1002/cpt.2493. Epub 2021 Dec 17. Clin Pharmacol Ther. 2022. PMID: 34826137 Clinical Trial.
References
-
- Wilhelm J, Mishina E, Viray L, Paredes A. & Pickworth WB The pH of Smokeless Tobacco Determines Nicotine Buccal Absorption: Results of a Randomized Crossover Trial. Clin Pharma and Therapeutics cpt.2493 (2021). - PubMed
-
- Stanfill S. et al. Characterization of Total and Unprotonated (Free) Nicotine Content of Nicotine Pouch Products. Nicotine & Tobacco Research 23, 1590–1596 (2021). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
